Home Tags Life Sciences

Tag: Life Sciences

Ireland: On the Road to Economic and Employment Recovery

Ireland is forecast to experience robust growth during 2016 and 2017. Due in part to the country’s per capita GDP gradually returning to pre-financial crisis levels. Despite the still settling political climate, the Irish have much to be optimistic about as the country has put the worst years of its financial crisis behind it. The economy expanded by 6.9%...

Russia: Life Sciences Growth Forecast to Continue Despite Challenges

Russia is home to the largest pharmaceutical market in Central and Eastern Europe, with increased manufacturing, sales and development activity expanding through local investment. Revenues are forecasted with continued growth well into 2018. This is anticipated to drive ongoing hiring activity in most sectors despite recent job cuts in the technology and manufacturing industries, due in part to the...

Mexico: Expiring Drug Patents Boost Hiring in Biotechnology

Mexico has a winning strategy for the development, production and distribution of generic drugs. The region boasts the largest penetration of generic drugs of any country on the globe with 84% in 2013, up from 50% in 2010. Reports for 2012 estimated Mexican generic drug sales revenue at $3.4 billion, or 2% of the world market. Projections that growth...

India: Pharmaceutical Market Continues To Be One of the Fastest Growing in the World

Pharmaceutical companies, both Indian and multi-nationals, should continue to leverage India’s large raw material base and the availability of a skilled workforce to maintain a competitive advantage over their peers. The sector, one of the largest in the world, is knowledge based, growing steadily and playing a major role in the Indian economy. India’s pharmaceutical industry’s worth is expected to...

Switzerland: Showing Continued Strength in Life Sciences

The Swiss continue to dominate the global landscape in the area of Life Sciences. Ranking second globally for pipelines in all phases and boasting 14.1 per 1000 individuals in the labor force in Research and Development, Switzerland is 4.7 people ahead of the regional average. By comparison Germany had less than one individual fewer than Switzerland (per thousand); however,...

Finland: Growth Predicted for Innovative Life Sciences Industry

Finland’s life sciences industry benefits from the country’s highly educated workforce, geopolitical position, and governmental bodies. Finland has continually been ranked as one of the least corrupt countries in the world and has been ranked at the top of the WEF’s Environmental Sustainability Index since 2000. Finland has a stable, small, and open economy that attracts research, funding, and...

Ireland: Location and Exports Contribute to Flourishing Life Sciences Industry

Ireland is one of the leading locations for the pharmaceutical industry in Europe, and the country offers a wide range of products and services – from the research and development of new medicines to the manufacture and marketing of these medicines for human and animal consumption. The industry is comprised of a mix of international and local companies. Approximately 120...

Germany: Looking to Immigration to Meet High Demand for Professionals in Life Sciences Industry

Germany’s life sciences sector is the largest in Europe and the third largest globally. The sector encompasses a majority of life sciences activity, including biotechnology, pharmaceuticals, and medical devices. Oncology and the chemical and pharmaceutical industries are strong areas for Germany. Oncology accounts for about 34 percent of the total product development in the biotechnology therapeutics and pharmaceuticals industries....

Belgium: Increased Growth Seen in Thriving Life Sciences Industry

While Belgium makes up just 2.6 percent of overall European GDP, they contribute to a significant percentage of the overall European life sciences industry. Belgium has active biotechnology and pharmaceutical sectors and contributes to 4.7 percent of overall European pharmaceutical employment, 3.2 percent European pharmaceutical R&D, 7.8 percent of total sector expenditure, and 12 percent of sector exports. The Belgian...

France: Life Sciences Industry Major Contributor to Commercial Economy

The French economy represents nearly one-third of the European market, with R&D investment in the life sciences sector coming second to only the automotive industry. While their life sciences sector represents just 40,000 jobs within the country, mostly in Ile de France and Rhône-Alpes, the sector maintains a priority for the French government due to the country’s internal demographics,...